paclitaxel,sotigalimab,nivolumab
bms
['prince', 'prostate', 'crpc']
impressive initial results of prince trial in mcrpc: psa rr &gt; 50 - 76%. looking forward further phase 2/3 trials of this combination with bigger patients sample size. #asco22 #prostatecancer #immunotherapy 
Medical Oncologist. GU & GI tumors. LACOG-GU Scientific Committee. Santa Lúcia Hospital. University Hospital of Brasilia. Maratonist & Triathlete (2x IronMan).